Cargando…

Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature

BACKGROUND: To validate the expression of a urine-based bladder cancer associated diagnostic signature comprised of 10 targets; ANG, CA9, MMP9, MMP10, SERPINA1, APOE, SDC1, VEGFA, SERPINE1 and IL8 in bladder tumor tissues. METHODS: Immunohistochemical analyses were performed on tumor specimens from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ge, Gomes-Giacoia, Evan, Dai, Yunfeng, Lawton, Adrienne, Miyake, Makito, Furuya, Hideki, Goodison, Steve, Rosser, Charles J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245773/ https://www.ncbi.nlm.nih.gov/pubmed/25387487 http://dx.doi.org/10.1186/s13000-014-0200-1

Ejemplares similares

Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditions
por: Miyake, Makito, et al.
Publicado: (2013)

Investigation of CCL18 and A1AT as potential urinary biomarkers for bladder cancer detection
por: Miyake, Makito, et al.
Publicado: (2013)

Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers
por: Miyake, Makito, et al.
Publicado: (2013)

Influencing factors on the NMP-22 urine assay: an experimental model
por: Miyake, Makito, et al.
Publicado: (2012)

Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancer
por: Miyake, Makito, et al.
Publicado: (2014)

Simultaneous multi-analyte urinary protein assay for bladder cancer detection
por: Rosser, Charles J, et al.
Publicado: (2014)

Matrix metalloproteinase-10 promotes tumor progression through regulation of angiogenic and apoptotic pathways in cervical tumors
por: Zhang, Ge, et al.
Publicado: (2014)

A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort
por: Goodison, Steve, et al.
Publicado: (2016)

Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer
por: Masuda, Norihiko, et al.
Publicado: (2018)

CCL18 in a Multiplex Urine-Based Assay for the Detection of Bladder Cancer
por: Urquidi, Virginia, et al.
Publicado: (2012)

Intravesical ALT-803 and BCG Treatment Reduces Tumor Burden in a Carcinogen Induced Bladder Cancer Rat Model; a Role for Cytokine Production and NK Cell Expansion
por: Gomes-Giacoia, Evan, et al.
Publicado: (2014)

A microRNA biomarker panel for the non-invasive detection of bladder cancer
por: Urquidi, Virginia, et al.
Publicado: (2016)

A multiplex immunoassay for the non-invasive detection of bladder cancer
por: Shimizu, Yoshiko, et al.
Publicado: (2016)

Bladder Cancer Detection and Monitoring: Assessment of Urine- and Blood-Based Marker Tests
por: Goodison, Steve, et al.
Publicado: (2013)

CXCL1 is elevated in the urine of bladder cancer patients
por: Burnier, Andre, et al.
Publicado: (2015)

Diagnostic performance of Oncuria™, a urinalysis test for bladder cancer
por: Hirasawa, Yosuke, et al.
Publicado: (2021)

A Multi-Analyte Assay for the Non-Invasive Detection of Bladder Cancer
por: Goodison, Steve, et al.
Publicado: (2012)

A Diagnostic Gene Expression Signature for Bladder Cancer Can Stratify Cases into Prescribed Molecular Subtypes and Predict Outcome
por: Chen, Runpu, et al.
Publicado: (2022)

Urinary mRNA biomarker panel for the detection of urothelial carcinoma
por: Urquidi, Virginia, et al.
Publicado: (2016)

Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth
por: Miyake, Makito, et al.
Publicado: (2019)

IL-8 as a urinary biomarker for the detection of bladder cancer
por: Urquidi, Virginia, et al.
Publicado: (2012)

Association of SNPs in the PAI1 Gene with Disease Recurrence and Clinical Outcome in Bladder Cancer
por: Murakami, Kaoru, et al.
Publicado: (2023)

Application of a multiplex urinalysis test for the prediction of intravesical BCG treatment response: A pilot study
por: Murakami, Kaoru, et al.
Publicado: (2022)

Comparison of Commercial ELISA Kits, a Prototype Multiplex Electrochemoluminescent Assay, and a Multiplex Bead-Based Immunoassay for Detecting a Urine-Based Bladder-Cancer-Associated Diagnostic Signature
por: Furuya, Hideki, et al.
Publicado: (2019)

Influencing Factors on the Oncuria™ Urinalysis Assay: An Experimental Model
por: Murakami, Kaoru, et al.
Publicado: (2021)

Immunohistochemical detection of hTERT in urothelial lesions: a potential adjunct to urine cytology
por: Khalbuss, Walid, et al.
Publicado: (2006)

Locally advanced paraganglioma of the urinary bladder: a case report
por: Beilan, Jonathan, et al.
Publicado: (2013)

Pheochromocytoma of the urinary bladder: a systematic review of the contemporary literature
por: Beilan, Jonathan A, et al.
Publicado: (2013)

Diagnostic approach for cancer cells in urine sediments by 5-aminolevulinic acid-based photodynamic detection in bladder cancer
por: Miyake, Makito, et al.
Publicado: (2014)

Diagnostic and Prognostic Roles of Urine Nectin-2 and Nectin-4 in Human Bladder Cancer
por: Miyake, Makito, et al.
Publicado: (2023)

Analytical validation of ONCURIA™ a multiplex bead-based immunoassay for the non-invasive bladder cancer detection
por: Furuya, Hideki, et al.
Publicado: (2020)

Active surveillance for nonmuscle invasive bladder cancer
por: Miyake, Makito, et al.
Publicado: (2016)

Pretreatment assessment and perioperative nutritional interventions for patients with bladder cancer undergoing radical cystectomy
por: Miyake, Makito, et al.
Publicado: (2018)

Colony-stimulating factors detected in tumor cells and voided urine are potential prognostic markers for patients with muscle-invasive bladder cancer undergoing radical cystectomy
por: Morizawa, Yosuke, et al.
Publicado: (2018)

Prostate diseases and microbiome in the prostate, gut, and urine
por: Miyake, Makito, et al.
Publicado: (2022)

Prognostic Significance of Lymphocyte Infiltration and a Stromal Immunostaining of a Bladder Cancer Associated Diagnostic Panel in Urothelial Carcinoma
por: Furuya, Hideki, et al.
Publicado: (2019)

PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity
por: Furuya, Hideki, et al.
Publicado: (2022)

Prognostic cancer gene signatures share common regulatory motifs
por: Wang, Ying, et al.
Publicado: (2017)

Radiosensitization in prostate cancer: mechanisms and targets
por: Palacios, Diego A, et al.
Publicado: (2013)

Angiogenin contributes to bladder cancer tumorigenesis by DNMT3b-mediated MMP2 activation
por: Peres, Rafael, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gbt72pg5aklq6o46mm67ecq5r4